Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: why the tight confidentiality? palomar...bill
4
Dec 19, 2007 08:18AM

There are ways to structure the deal so that revenues would be recognized over time - recurring royalties based on a percentage of revenues would be one. Those types of agreements would still be spelled out in the notes to the financial statements so we would be aware of the possible future revenues. You hit the nail on the head when you referred to when the money is "earned", that being one of the controlling factors.


Dec 19, 2007 11:53AM
3
Dec 19, 2007 12:26PM

Dec 19, 2007 12:40PM
Share
New Message
Please login to post a reply